Aurelio Lorico,
Professor of Pathology,
Touro University Nevada School of Medicine
Aurelio Lorico, MD, PhD is Full Professor of Pathology at Touro University Nevada Medical School and Adjunct Clinical Researcher at the Mediterranean Institute of Oncology. He is an Editorial Board member of Cells. He began his scientific career as a cancer pharmacologist, working on topoisomerase II-targeted drugs with Alan Sartorelli at Yale University, where he identified MRP1 as a co-transporter of drugs and glutathione. Next, he worked on cancer gene therapy at the Norwegian Cancer Center in Oslo. Back to the US, he became intrigued with cell-cell interactions in the cancer microenvironment and extracellular vesicles (EVs). His lab studies EVs as potential diagnostic and prognostic markers in liquid biopsies from cancer patients and investigates the intracellular fate of EV-associated molecules in recipient cells. Dr. Lorico’s lab is currently also developing anti-cancer therapies based on drugs or antibodies that interfere with a novel EV intracellular pathway.
|
|
|